Healthcare Services Group (HCSG) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
24 Apr, 2026Business overview and market position
Leading provider of environmental, dining, and nutrition services to healthcare facilities, servicing over 2,800 facilities with approximately 36,000 employees across 48 states.
Holds over 80% share in both environmental and dietary services among outsourced providers, with less than 15% and 8% of the addressable market currently outsourced, respectively.
Recurring revenues and a strong balance sheet support a market-leading client retention rate above 90%.
Industry trends and growth drivers
U.S. population aged 85+ is projected to grow 168% from 2022 to 2050, driving demand for long-term care services.
By 2030, over 170 million Americans will have at least one chronic condition, and 70% of today’s 65-year-olds are expected to require long-term care.
Expansive geographic footprint and untapped organic growth levers position the business for continued expansion.
Financial performance and outlook
2025 revenue reached $1.84B, with environmental services contributing $825M and dietary services $1.01B.
Adjusted EBITDA for Q1 2026 was $38.9M, up from $29.2M in Q1 2025; operating cash flow for Q1 2026 was $32.1M.
2026 outlook projects mid-single digit revenue growth, EBITDA margins of 5.5%, and operating cash flow expected to mirror net income.
Latest events from Healthcare Services Group
- Q1 2026 saw 3.4% revenue growth, 51% higher net income, and robust share repurchases.HCSG
Q1 202624 Apr 2026 - Shareholders to vote on directors, pay, auditor, and equity plan amid strong growth and governance.HCSG
Proxy filing15 Apr 2026 - Revenue up 7.1% to $1.84B, net income $59.1M, $75M buyback, 2026 growth outlook strong.HCSG
Q4 202511 Feb 2026 - Q2 revenue rose 1.8% to $426.3M, but a large bad debt charge drove a net loss of $1.8M.HCSG
Q2 20243 Feb 2026 - Q3 2024 revenue and net income grew, with strong cash flow and reaffirmed guidance.HCSG
Q3 202419 Jan 2026 - Q1 2025 saw record revenue, higher net income, and raised cash flow guidance.HCSG
Q1 202523 Dec 2025 - Q4 revenue grew to $437.8M, but net income and margins fell; 2025 growth expected.HCSG
Q4 202423 Dec 2025 - 2024 saw growth, high retention, and strong governance, with key votes on directors, pay, and audit.HCSG
Proxy Filing1 Dec 2025 - Q2 revenue up 7.6%, $61.2M charge drives $32.4M loss, $50M buyback and higher cash flow planned.HCSG
Q2 202516 Nov 2025